CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diagnostear Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diagnostear Technologies Inc
Manachem Plant 10
REHOVOT, BC  7670621  Israel Ticker: DTRDTR
Business Summary
DiagnosTear Technologies Inc is an Israel-based company operating in the ophthalmic diagnostics sector. The Company develops the TeaRx™ technology, a tear-fluid analytical platform designed for identifying and monitoring front-of-the-eye diseases. It focuses on research and development of diagnostic tests, clinical validation activities, regulatory readiness, and establishing production capabilities, supported partly through government-funded research and development(R&D) programs. The Company operates through a single reportable segment dedicated to tear-based ophthalmic diagnostic solutions, including test development, production line preparation, commercialization planning, and ongoing enhancement of its technological capabilities.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board YaacovMichlin 55 4/1/2020 4/1/2020
Chief Executive Officer ShimonGross 54 10/25/2022 10/25/2022
Chief Financial Officer, Director YifftachBiel 48 10/1/2020 10/1/2020
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 60,838,335 (As of 12/15/2025)
Stock Exchange: CNQ


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, February 18, 2026